Lenograstim

• Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients … Pending
  2024-517295-37-00 Phase III 1 country University Of Cologne
• A single arm, open label, multicenter, single-dose, phase 2b clinical study evaluating efficacy and safety of gene therapy using autologous … Pending
  2025-522160-32-00 Phase II 1 country Fondazione Telethon Ets; San Raffaele Hospital
• A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects with WAS. Recruiting
  2024-517792-20-00 Phase III 1 country Fondazione Telethon Ets
• A prospective program aiming at improving outcome for young adults with poor-prognosis non seminomatous germ-cell tumors (VAPOR (GETUG T06)) Recruiting
  2023-505040-19-00 Phase II 1 country Institut Gustave Roussy
• The study's aim is to treat adult patients affected by Ph-like ALL, a Philadelphianegative ALL subtype, with a combination of the tyrosine k… Recruiting
  2023-510240-20-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended
  2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• Gene therapy study with autologous hematopoietic stem cells for patients affected by MPS-IH Ended
  2024-514870-29-00 Phase I (FiH) 1 country Orchard Therapeutics (Europe) Limited
• A clinical gene therapy study with hematopoietic stem cells for the treatment, with single dose of Temferon, of patients suffering from meta… Ended
  2024-512898-27-00 Phase I/II 1 country Genenta Science S.p.A.

Showing 1–8 of 8 trials